Ruxolitinib for Adult T-Cell Leukemia

Clinical trial NCT01712659 · TERMINATED

Trial details

NCT number: NCT01712659
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T Cell Leukemia, Adult Leukemia, Adult T-Cell T Cell Leukemia, HTLV I Associated

Start date: 2012-10-26
Primary completion: 2021-11-12
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.